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Through advances in therapy and technology, the quality
of life, morbidity and mortality outcomes in people with
type 1 diabetes continue to improve in countries with
well-developed health-care systems, but major disparities
in diabetes care exist globally. Ideally, an individual with
type 1 diabetes should be managed by a multidisciplinary
healthcare team delivering integrated clinical care. Essen-
tial to the delivery of optimal diabetes care is education of
health care teams, individuals, the community and policy
makers. Evidence based clinical care guidelines are an
important component of such education. However, while
guidelines provide guidance for the practice of evidence
based care at the organisational level, evidence based med-
icine requires the integration of research evidence with
clinical expertise and patient values. Since many aspects of
health care depend on individual factors such as quality of
life, guidelines should be used in the context of the health-
care needs and circumstance of each individual with dia-
betes. Globally, the practicality of implementing evidence
based recommendations also depends on the health sys-
tem structure, availability of resources, economic consid-
erations and socio-cultural factors.
There are a range of guidelines available for the manage-
ment of young people with type 1 diabetes, including
those produced by NICE, ADA, ISPAD and IDF. In Aus-
tralia, evidence-based guidelines for management of type 1
diabetes across the lifespan were launched in November
2011 [1]. Through the collaborative efforts of the Australa-
sian Paediatric Endocrine Group (http://www.apeg.org.au)
and the Australian Diabetes Society (http://www.diabetes-
society.com.au), the guidelines address key aspects of
diabetes care, based on the best available evidence at the
time of writing. The guidelines are structured around
clinical questions addressed by systematic reviews and
meta-analyses. Notably, evidence for rapidly evolving areas
such as use of technologies (pumps, continuous glucose
monitoring) is constantly changing. Furthermore, there
are aspects of care for which there is little or no evidence,
so management is based on best practice or consensus.
The applicability of these and other contemporary guide-
lines to the Asia Pacific Region will be reviewed.
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